Clinical trial
Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac…
NCT00348101 · Klinikum Ludwigshafen, Other · Completed
Key facts
| NCT number | NCT00348101 |
|---|---|
| Title | Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation |
| Official title | The Influence of Continuous Perioperative Beta-Blocker Therapy in Combination With Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation and Myocardial Ischaemia in High-Risk Vascular Surgery Patients |
| Lead sponsor | Klinikum Ludwigshafen, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Combined therapy with enoximone and esmolol |
| Enrollment | 75 |
| Start date | Jun 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | May 30, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: